FDA is­sues draft guid­ance aimed at curb­ing man­u­fac­tur­ing short­ages

The FDA is hop­ing that its lat­est draft guid­ance will lead to bet­ter in­for­ma­tion about po­ten­tial drug and ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) short­ages from man­u­fac­tur­ers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER